247 related articles for article (PubMed ID: 975053)
1. Immunological enhancement of leukemia L1210 by Corynebacterium parvum in allogeneic mice.
Berd DA; Mitchell MS
Cancer Res; 1976 Nov; 36(11 Pt 1):4119-24. PubMed ID: 975053
[TBL] [Abstract][Full Text] [Related]
2. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
3. Effect of Corynebacterium parvum on cellular and humoral antitumoral immune effector mechanisms.
Mantovani A; Tagliabue A; Vecchi A; Spreafico F
Eur J Cancer (1965); 1976 Feb; 12(2):113-23. PubMed ID: 1083341
[No Abstract] [Full Text] [Related]
4. Immunomodulation by Corynebacterium parvum. 1. Variable effects on anti-sheep erythrocyte antibody responses.
Ghaffar A; Sigel MM
Immunology; 1978 Nov; 35(5):685-93. PubMed ID: 363603
[TBL] [Abstract][Full Text] [Related]
5. Analysis and reversal of the inhibition of cytophilic antibody receptors produced by antibody.
Mitchell MS; Mokyr MB; Goldwater DJ
Cancer Res; 1975 May; 35(5):1121-7. PubMed ID: 1078991
[TBL] [Abstract][Full Text] [Related]
6. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
Rao VS; Mitchell MS
J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
[TBL] [Abstract][Full Text] [Related]
7. Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
Fuji H; Mihich E
Cancer Res; 1975 Apr; 35(4):946-52. PubMed ID: 1090366
[TBL] [Abstract][Full Text] [Related]
8. Cell-mediated immune responses in vitro. II. Simultaneous generation of cytotoxic lymphocyte responses to two sets of alloantigens of limited cross-reactivity.
Peavy DL; Pierce CW
J Immunol; 1975 Dec; 115(6):1515-20. PubMed ID: 1184965
[TBL] [Abstract][Full Text] [Related]
9. Functional heterogeneity in macrophages activated by Corynebacterium parvum: characterization of subpopulations with different activities in promoting immune responses and suppressing tumor cell growth.
Lee KC; Berry D
J Immunol; 1977 May; 118(5):1530-40. PubMed ID: 323353
[TBL] [Abstract][Full Text] [Related]
10. Effects of different fractions of Corynebacterium parvum on the cytotoxic T-cell response to alloantigens in mice.
Lichtenstein A; Tuttle R; Cantrell J; Zighelboim J
J Natl Cancer Inst; 1982 Aug; 69(2):495-501. PubMed ID: 6213807
[TBL] [Abstract][Full Text] [Related]
11. Further studies on the enhancement of the antibody response in vitro by C. parvum.
Slijivíc VS; Brown CA; Watson SR
Dev Biol Stand; 1977 Apr 13-15; 38():147-52. PubMed ID: 608502
[TBL] [Abstract][Full Text] [Related]
12. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
13. Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.
Miyata H; Himeno K; Miake S; Nomoto K
Immunology; 1981 Oct; 44(2):305-10. PubMed ID: 7298070
[TBL] [Abstract][Full Text] [Related]
14. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
Orsini F; Pavelic Z; Mihich E
Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
[TBL] [Abstract][Full Text] [Related]
15. Effect of Corynebacterium parvum on the course of a Listeria monocytogenes infection in normal and congenitally athymic (nude) mice.
Ruittenberg EJ; van Noorle Jansen LM
Zentralbl Bakteriol Orig A; 1975; 231(1-3):197-205. PubMed ID: 808049
[TBL] [Abstract][Full Text] [Related]
16. Suppression of secondary cellular immunity to a tumor allograft by cyclophosphamide and 1,3-bis(2-chloroethyl)-1-nitrosourea.
Einstein AB; Fass L; Fefer A
Cancer Res; 1975 Mar; 35(3):492-6. PubMed ID: 1078784
[TBL] [Abstract][Full Text] [Related]
17. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
18. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
Murahata RI; Mitchell MS
J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
[TBL] [Abstract][Full Text] [Related]
19. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
Leu RW; Leu NR; Shannon BJ; Fast DJ
J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
[TBL] [Abstract][Full Text] [Related]
20. The cells involved in the modification of the in vitro immune response by Corynebacterium parvum (C. parvum).
Liacopoulos-Briot M; Lambert F; Halpern B
Dev Biol Stand; 1977 Apr 13-15; 38():215-21. PubMed ID: 344096
[No Abstract] [Full Text] [Related]
[Next] [New Search]
